Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic Bronchoscopy [Phase 3]

View source ↗

Summary

Phase 3 trial update for HSK3486 Injectable Emulsion assessing efficacy and safety during fiberoptic bronchoscopy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation or Anesthesia

Drugs mentioned

• HSK3486 injectable emulsion (HSK3486)

Snippet

Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Sedation or Anesthesia | Phase 3 | Status: COMPLETED